Cannabis Global (Cannabis Global) EBIT per Share : $-0.01 (TTM As of May. 2022)

View and export this data going back to 2008. Start your Free Trial

What is Cannabis Global EBIT per Share?

Cannabis Global's EBIT per Share for the three months ended in May. 2022 was $0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in May. 2022 was $-0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Cannabis Global's EBIT per Share or its related term are showing as below:

CBGL's 3-Year EBIT Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.45
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Cannabis Global's EBIT for the three months ended in May. 2022 was $-0.21 Mil.

Cannabis Global EBIT per Share Historical Data

The historical data trend for Cannabis Global's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Global EBIT per Share Chart

Cannabis Global Annual Data

Trend

Aug12

Aug13

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

EBIT per Share

Get a 7-Day Free Trial

-0.01

-0.03

-0.21

-0.01

Cannabis Global Quarterly Data
	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22
EBIT per Share	Get a 7-Day Free Trial															0.01	-0.02	-	0.01	-

Cannabis Global EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Cannabis Global's EBIT per Share for the fiscal year that ended in Aug. 2021 is calculated as

	EBIT per Share		(A: Aug. 2021 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.679	/	58.289
=	-0.01

Cannabis Global's EBIT per Share for the quarter that ended in May. 2022 is calculated as

	EBIT per Share		(Q: May. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.205	/	516.732
=	-0.00

EBIT per Share for the trailing twelve months (TTM) ended in May. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

Cannabis Global (OTCPK:CBGL) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Cannabis Global EBIT per Share Related Terms

Thank you for viewing the detailed overview of Cannabis Global's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabis Global (Cannabis Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Global Inc (OTCPK:CBGL) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

520 S. Grand Avenue, Suite 320, Los Angeles, CA, USA, 90071

Website

https://www.cannabisglobalinc.com

Cannabis Global manufactures and distributes various cannabis products via its majority ownership of Natural Plant Extract, Inc is developing the Ethos Comply Bag, and generally conducts research and development in the areas of hemp, cannabis and consumer food goods. The company also have an active research and development program primarily focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Its product includes cannabis flower packaged in various weights, cannabis Pre-rolls, cannabis edible products.

Executives

Jim L. Riley	director	C/O CANNABIS GLOBAL INC., 520 S GRAND AVENUE, SUITE 320, LOS ANGELES CA 90071
Ghs Investments, Llc	10 percent owner	0830 SOUTH EASTERN AVENUE, #124-376, LAS VEGAS NV 89123
Hymers Iii R. Leslie	director, 10 percent owner	520 S GRAND AVENUE, STE 320, LOS ANGELES CA 90071
Arman Tabatabaei	director, officer: CEO, CFO	520 SOUTH GRAND AVENUE, SUITE 320, LOS ANGELES CA 90071
Lauderdale Holdings, Llc	director, 10 percent owner, officer: CEO/President/CFO	1919 NW 19 STREET, FT LAUDERDALE FL 33311
Harmel S Rayat	10 percent owner	700 - 688 WEST HASTINGS STREET, VANCOUVER A1 V6B 1P1
David A Gamache	director, officer: SECRETARY/TREASURER/CFO	3905 NATIONAL DRIVE, SUITE 110, BURTONSVILLE MD 20866
Meetesh V Patel	director, officer: PRESIDENT/CEO	8775 CENTRE PARK DRIVE, # 210, COLUMBIA MD 21045
Pattiann Hiranandani	director	3905 NATIONAL DRIVE, BURTONSVILLE MD 20866